Danone's Irini Schoeman-Giziakis discusses open innovation, nutrition in the GLP-1 era, and artificial intelligence.
The company is focused on meeting nutritional needs of people taking GLP-1 drugs or retaining weight loss after stopping them.
It's early days, says Irini Schoeman-Giziakis, Danone's open innovation manager.
Danone considers positioning existing products as "GLP-1 friendly" or guiding patients through nutrition or online shopping apps.
Author's summary: Danone explores open innovation and GLP-1 era nutrition.